Revil, Zamirah Jane .

HRN: 25-13-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/08/2026
01/15/2026
IV
470mg
Q6hours
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines